Timely reports on clinical research, legislative updates and product launches, from the editors of Review of Optometry and RCCL. Stories post each weekday morning.
Despite balanced participation based on sex, a new study uncovers significant underreporting of minority groups, urging for more equitable inclusion in future research.
Screenings went down in all populations except non-metropolitan statistical area communities, showing that a greater understanding of health disparities in these areas is needed.
Conducting VF testing, OCT and optic disc exams during initial and follow-up visits protected against short-term diagnostic changes, as did seeing a glaucoma specialist at the first visit, researchers found.
The new module produces colored maps and detailed parameters to assist in refractive surgery planning, ocular surface evaluation and more, according to the company.
Artificial tears, lid scrubs and patient counseling remain the most-used measures among a broad swathe of practitioners, according to a recent survey. Topical tacrolimus was the most common Rx therapy.
Reducing appointment burden, improving the availability and quality of educational materials and focusing on therapies to extend treatment intervals could potentially improve vision outcomes.
These providers will be added to the physician pay scale, helping the nation’s largest integrated healthcare system to recruit and retain more top-tier doctors.
A pattern-based model currently in development showed better sensitivity for detecting loss of tissue characteristic of the disease than RNFL and GCL+IPL thickness maps.
Meta-analysis found GLP-1 receptor agonist use in these patients was associated with a 29% decrease in risk, though results were not uniform across all studies.
Though causality could not be determined, researchers observed a higher incidence of the event among patients on GLP-1 receptor agonists than those taking other diabetes or weight loss medications.
After adjusting for BMI and other confounders, study suggests that social determinants of health may contribute to the condition through other mechanisms besides obesity alone.
Understanding associations between this medication use and the thinning of retinal regions could serve as an early diagnostic indicator for retinal toxicity.
The most effective medication classes in a recent study were topical CAI/beta-blocker combos and intracameral cholinergics. Topical alpha-agonists were the least effective.
Data shows a concerning relationship, emphasizing the need for heightened clinician awareness. Corneal toxicity from chronic topical therapy is one proposed mechanism.
Also, the time to resolution was significantly shorter in women and those with autoimmune etiologies, the latter perhaps because of greater vigilance in vulnerable patients.
The relationship argues for the contribution of non-IOP mechanisms in pathogenesis and could be used as a predictor of future disease development, researchers suggest.